BioEdge turns free public data (SEC EDGAR, openFDA, the Federal Register, and ClinicalTrials.gov) into a scored, agent-callable biotech-catalyst calendar: upcoming PDUFA dates, FDA advisory-committee meetings, and clinical-trial readouts. Each catalyst carries a research-backed approval-probability and expected-impact score with confidence and evidence flags, plus a unique SEC Form 4 insider cross-signal (were insiders buying before this catalyst?). Free tier: calendar and dates. Pro (29/mo): scores, insider signal, outcome history, and alerts. Signals, not recommendations; not investment advice.